A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
about
The role of vascular endothelial growth factor a polymorphisms in breast cancerPromoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans.Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms.Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in ChinaC936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinomaMTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans.VEGF 936C > T Polymorphism and Association of BI-RADS Score in Women with Suspected Breast Cancer.Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis.Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patientsPolymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.Vascular endothelial growth factor polymorphisms as effect modifiers of oral squamous cell carcinoma risk: A systematic review and meta-analysisOesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A.Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.VEGF polymorphisms and severity of atherosclerosis.Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome.Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDSVascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis.VEGF Gene Polymorphisms are Associated with Risk of Tetralogy of Fallot.A functional variant in the 3'-UTR of VEGF predicts the 90-day outcome of ischemic stroke in Chinese patientsVEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in JapaneseAssociation of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients.Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer.Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAssociation of vascular endothelial growth factor (VEGF) +405 g>c polymorphism with endometriosis in an Iranian populationGender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancerGenetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosisPrognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis.Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival.Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesisAngiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children.
P2860
Q26851522-A7FC1967-A5BA-4210-BBE5-C1779C88EB96Q33684757-F221824D-9493-4724-AFBA-99F2750F4EFCQ33828717-37DC7250-6DCF-4F32-A419-CDE5B81C8A73Q34341453-DB9924E2-16CC-45B3-929C-DB8A0E368A3DQ34466706-518E786E-7533-496B-970F-C8747164955EQ34469737-F1A56783-C86A-4F24-A103-62F4E16CC51CQ34692175-892F480E-511F-4A9A-9D01-A44D4E32F223Q34894525-70164B59-09CE-4FC9-8BC7-893E9796970BQ34908859-C625D658-EC73-4992-8A3F-550B571CC10CQ34990498-873FE446-AF7E-43F4-A098-CA237B90D32AQ34996947-E31604CF-8753-46B1-AB0E-722D2748590CQ35012794-F272AFFF-6E5F-4C6A-A7FC-B3348ADC404AQ35179707-06FD913B-D85B-40BF-B18F-CE6D2A8D7826Q35189242-8E30C5D0-BAFB-4488-8703-01D5757EAAFBQ35354678-F871656A-761F-4DE3-A089-9F78342A647EQ35448592-6D2D77F7-789B-403A-A15F-334C4DAB590CQ35709085-0453AF6B-4B66-4838-B924-8D8D28D59525Q35912389-3B876FBD-CAF5-4625-84CA-2C8D7A083E74Q35934127-C67FA392-9548-4BEF-8833-DCBAD586CC1CQ36225882-6C1B01B5-3E2F-43F4-8976-A3EBD515CBF6Q36230748-531FE80F-E7C8-4C7A-BCC3-0822254177D4Q36287686-5EA2193C-F496-4A95-AD87-B1B5DEC3A4D6Q36289803-378AFDE6-1EE5-4FA5-9782-3D3A7A994D63Q36541140-046A60F1-6D10-45CA-8A2B-AD290D112AACQ36638595-3B1EE842-92DD-4E81-B813-8A01BC657630Q36691776-5165CDEE-A6DB-44D1-A23C-43895FDCBFE3Q36746698-286067C9-B0DA-46FD-90BE-221E4D4EAC15Q36854622-6F1246EC-1B34-4ABB-ADAB-0D9CB914B1B8Q36982859-DAF9B535-20B8-4ACE-95F9-B41812ACB9DEQ37035051-D403C589-7031-4BF5-BD85-E615D8F94F1DQ37041198-F6CC19C8-595A-485B-BB1A-DA92A1F42693Q37090696-E7558377-CCE4-492B-802D-56062D4A1435Q37121685-36039EE6-C0FC-4C33-80B2-FCC9A5A157B8Q37180102-CC1CB114-4AF9-463D-89AB-EE416BFB1D05Q37187766-E1DA8FC1-9F40-4EAE-BB34-6C3714E50345Q37229446-E61BCEF6-1A6F-4C4B-8209-8C63201FBBDFQ37304321-C8BEF1D9-7913-472C-AEB9-E8EFCE603DE9Q37310665-0DF2CE53-658F-46CD-99CB-8CF0D94A377CQ37315498-0630F958-B426-4D2C-9DB3-79F52F1DFAE4Q37321890-F4B04B52-A73D-4213-806E-142B4681B880
P2860
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@en
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@nl
type
label
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@en
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@nl
prefLabel
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@en
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@nl
P2093
P356
P1476
A common 936 C/T gene polymorp ...... decreased breast cancer risk.
@en
P2093
Babak Yazdani-Biuki
Bernhard Paulweber
Gerald Wolf
Hellmut Samonigg
Josef Haas
Peter Krippl
Thomas C Wascher
Uwe Langsenlehner
Wilfried Renner
P304
P356
10.1002/IJC.11238
P577
2003-09-01T00:00:00Z